Carcinosarcomas (malignant mixed Mullerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
Kernochan LE, Garcia RL.
J Natl Compr Canc Netw. 2009 May;7(5):550-6; quiz 557. doi: 10.6004/jnccn.2009.0037.
Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases.
Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A.
Int J Gynecol Pathol. 1990;9(1):1-19. doi: 10.1097/00004347-199001000-00001.
Perivascular epithelioid cell tumor (PEComa) of the uterus: an outcome-based clinicopathologic analysis of 41 reported cases.
Fadare O.
Adv Anat Pathol. 2008 Mar;15(2):63-75. doi: 10.1097/PAP.0b013e31816613b0.
Malignant mixed mullerian tumors of the uterus. A clinicopathologic assessment of 34 cases.
Barwick KW, LiVolsi VA.
Am J Surg Pathol. 1979 Apr;3(2):125-35. doi: 10.1097/00000478-197904000-00003.
A malignant placental site trophoblastic tumor of the uterus with multiple metastases: A case report of a rare tumor showing an aggressive behavior.
Fathaddin AA, Arafah MA.
Indian J Pathol Microbiol. 2019 Jan-Mar;62(1):142-145. doi: 10.4103/IJPM.IJPM_45_18.
Primary malignant lymphoma of the uterus.
Fox H, More JR.
J Clin Pathol. 1965 Nov;18(6):723-8. doi: 10.1136/jcp.18.6.723.
Uterine leiomyosarcoma.
Hannigan EV, Gomez LG.
Am J Obstet Gynecol. 1979 Jul 1;134(5):557-64. doi: 10.1016/0002-9378(79)90841-x.
Carcinoma (malignant mixed mullerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
Costa MJ, Khan R, Judd R.
Arch Pathol Lab Med. 1991 Jun;115(6):583-90.
Patterns of recurrence in malignant mixed mullerian tumor of the uterus.
Spanos WJ Jr, Peters LJ, Oswald MJ.
Cancer. 1986 Jan 1;57(1):155-9. doi: 10.1002/1097-0142(19860101)57:1<155::aid-cncr2820570131>3.0.co;2-c.
Review literature on uterine carcinosarcoma.
Singh R.
J Cancer Res Ther. 2014 Jul-Sep;10(3):461-8. doi: 10.4103/0973-1482.138197.
